AdvisorShares Pure US Cannabis ETF (MSOS) seeks to provide investment results that correspond to companies primarily engaged in the legal cannabis and hemp ecosystem in the United States. This thematic equity ETF targets businesses involved in cannabis cultivation, processing, retail, ancillary services, and hemp-derived CBD products.
How It Works
MSOS employs an actively managed approach, with portfolio managers selecting U.S. cannabis companies based on fundamental analysis and growth potential. The fund focuses on multi-state operators, cannabis retailers, cultivation facilities, and ancillary service providers like real estate and technology companies serving the industry. Holdings are weighted based on market capitalization and growth prospects, with quarterly rebalancing to capture evolving opportunities in this rapidly changing sector.
Key Features
- Pure-play U.S. cannabis exposure targeting multi-state operators and ancillary businesses in America's legal marijuana market
- Active management allows flexibility to capitalize on regulatory changes and emerging opportunities within cannabis legalization
- Focuses on established operators with multi-state licenses rather than speculative early-stage cannabis ventures
Risks
- This ETF can lose substantial value if federal cannabis legalization stalls or reverses, as regulatory uncertainty drives extreme volatility
- Banking restrictions and cash-only operations create operational risks that could severely impact individual company valuations and fund performance
- High concentration in emerging cannabis sector means 50-80% declines possible during market downturns or regulatory setbacks
Who Should Own This
Best suited as a small satellite holding (2-5% of portfolio) for aggressive investors with high risk tolerance and 3+ year time horizons. Requires strong conviction in U.S. cannabis legalization trends. Appropriate for speculative investors seeking thematic exposure to marijuana industry growth, not conservative portfolios.